Overview

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder (TPIP) in Healthy Participants

Status:
Completed

Trial end date:
2021-01-12

Target enrollment:

Participant gender:

Summary

The primary purpose of this study is to evaluate the safety and tolerability of single and multiple doses of treprostinil palmitil inhalation powder in healthy participants.

Phase:

Phase 1

Details

Lead Sponsor:

Insmed Incorporated

Treatments:

Treprostinil